Provided by Tiger Trade Technology Pte. Ltd.

Sunshine Biopharma Inc.

1.24
+0.10008.77%
Post-market: 1.23-0.0138-1.11%19:05 EDT
Volume:9.36M
Turnover:11.55M
Market Cap:4.81M
PE:-0.12
High:1.31
Open:1.30
Low:1.01
Close:1.14
52wk High:24.30
52wk Low:1.01
Shares:3.88M
Float Shares:3.81M
Volume Ratio:53.10
T/O Rate:245.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.0329
EPS(LYR):-14.3739
ROE:-21.92%
ROA:-9.91%
PB:0.17
PE(LYR):-0.09

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Jul 20, 2026

Major Issues Report

Form 8-K - Current report
Jul 10, 2026

Major Issues Report

Form 8-K - Current report
Jul 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 29, 2026

Major Issues Report

Form 8-K - Current report
May 22, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 22, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 20, 2026

Major Issues Report

Form 8-K - Current report
May 18, 2026

Correspondence

Form CORRESP - Correspondence
May 18, 2026

Correspondence

Form CORRESP - Correspondence
May 15, 2026

Correspondence

Form CORRESP - Correspondence
May 15, 2026

Correspondence

Form CORRESP - Correspondence
May 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 09, 2026

Major Issues Report

Form 8-K - Current report
Apr 03, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2026

Major Issues Report

Form 8-K - Current report